GlassScriptPhysician profile
Stacey L June
NPI 1568609121
$2,346.25
in general payments reported to CMS, 2019-2025
28 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $15.59 · 2021: $44.59 · 2022: $179 · 2023: $1,117 · 2024: $505 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,620 · Travel and Lodging: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,619.99 |
| Travel and Lodging | $347.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $591.05 | 2023 | |
| Abbvie INC. | $218.67 | 2023-2025 | |
| Tela Bio, INC. | $193.97 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Endo USA, INC. | $189.85 | 2024-2025 | Xiaflex |
| Incyte Corporation | $151.32 | 2023-2025 | Opzelura |
| Musculoskeletal Transplant Foundation INC. | $144.43 | 2019-2024 | |
| Mentor Worldwide LLC | $139.70 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Smith+Nephew, INC. | $136.86 | 2021-2025 | Stravix, Grafix |
| Endo Pharmaceuticals INC. | $96.22 | 2022-2024 | Xiaflex |
| Allergan, INC. | $56.64 | 2019-2022 | |
| Leo Pharma INC. | $54.14 | 2023-2024 | Adbry |
| Solventum Corporation | $43.79 | 2024 | Activ.A.C., Promogran Prisma, V.A.C.Ulta |
| Regeneron Healthcare Solutions, INC. | $39.14 | 2023-2025 | Libtayo |
| Sonex Health, INC. | $38.83 | 2022-2024 | Sx-One Microknife |
| Dilon Technologies, INC. | $28.00 | 2025 | Hemoblast Bellows |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $24.69 | 2019-2022 | |
| Arteriocyte Medical Systems, INC. | $22.07 | 2019 | |
| Kerecis Limited | $19.38 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Takeda Pharmaceuticals U.S.A., INC. | $19.26 | 2019 | |
| Amag Pharmaceuticals, INC. | $17.79 | 2019 | |
| Integra Lifesciences Corporation | $16.90 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Nabriva Therapeutics, Plc | $16.85 | 2022 | |
| Sun Pharmaceutical Industries INC. | $16.70 | 2023 | Blu-U, Odomzo |
| Innovation Technologies INC | $15.66 | 2025 | Irrisept |
| Pharmacyclics LLC, An Abbvie Company | $15.59 | 2020 | |
| Sanara Medtech INC. | $14.85 | 2025 | Celleraterx |
| Jazz Pharmaceuticals INC. | $12.31 | 2019 | |
| Baudax Bio INC. | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey June listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.